CHDI Foundation Patent - Deuterated Compounds for Huntingtin Imaging

USPTO issued Patent US12606570B2 to CHDI Foundation, Inc., granting exclusive rights to deuterated compounds and imaging agents useful for detecting huntingtin protein aggregation associated with Huntington disease. The patent covers compounds, compositions, and methods of use, with 8 claims assigned to seven named inventors.

This patent grant represents a routine IP event that establishes enforceable intellectual property rights for CHDI Foundation. Researchers developing Huntington disease imaging agents or studying protein aggregation should conduct freedom-to-operate analyses to ensure their work does not infringe these claims.